Navigation Links
Medical experts: US unlikely to have enough vaccines to stop avian flu

A group of medical experts who attended a national avian flu conference last fall believe there is little chance the United States will be able to manufacture and stockpile enough vaccine or antiviral medication to stop a bird flu pandemic should the virus mutate into a form that can be spread easily from human to human, according to a survey led by researchers at Carnegie Mellon University. The results of the survey will be published in the June 2006 issue of the journal Global Public Health.

The 19 medical experts who attended the Pandefense 1.0 meeting in November gave a median estimate of a less than 1 percent chance that the U.S. will have adequate stockpiles of vaccines or antiviral drugs to prevent a pandemic within the next three years. The same experts gave a median estimate of 15 percent for the probability that the avian flu virus will mutate into a strain that can spread efficiently by human-to-human contact within that time. Their median worst-case estimate of the number of people who would die, should that happen, was 6 million in the United States and 180 million worldwide. Their median best-case estimates were 500,000 dead in the United States and 20 million worldwide.

"It surprised me that they thought it was going to be this bad," said Wändi Bruine De Bruin, lead author of the study and research faculty member in the Department of Social and Decision Sciences at Carnegie Mellon.

The survey also included 17 non-medical experts from a variety of fields who were more pessimistic about the likelihood of human-to-human transmission, giving a median 60 percent chance that it would occur within three years. They did, however, have more faith in medical science, giving a median 15 percent chance of the United States having enough vaccine and a 30 percent chance that the nation would have enough antiviral medications to halt a pandemic.

"The medical experts' estimates suggest this is a bigger risk than anything else we are fa cing," said Baruch Fischhoff, a study co-author and the Howard Heinz University Professor of Social and Decision Sciences and Engineering and Public Policy at Carnegie Mellon.

Both the medical and the non-medical experts agreed that the greatest hope for mitigating the effects of an avian flu outbreak among humans lies in heightened global surveillance and, should the virus become pandemic, hand washing, mask wearing and social distancing. Unfortunately, the efficacy of such strategies in preventing the spread of infectious diseases has not been extensively studied, Bruine de Bruin said. Although the federal government has expressed a commitment to open communication about these risks, its messages have not yet been scientifically evaluated, according to Fischhoff.


'"/>

Source:Carnegie Mellon University


Related biology news :

1. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. Medical whistleblowers speak out
4. Access to antiretrovirals unlikely to reduce HIV infection rates
5. Ozone recovering, but unlikely to stabilize at pre-1980 levels, says study
6. Gene therapy to lower blood pressure just enough
7. A little telomerase isnt enough
8. Heart has enough oxygen to survive hypothermia, CPR crucial
9. Walking not enough for significant exercise benefits
10. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
11. Increase in drug development for killer diseases is not enough
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
Breaking Biology Technology: